In the tumor immune microenvironment, CD4+ T cells can stimulate and maintain the differentiation of macrophages, CD8+ T cells and NK cells by secreting cytokines such as IFN-γ, TNF and IL-2, and inhibit angiogenesis of tumor, thus playing an anti-tumor effect (34–36). This evidence concerns the gene CD8A and neoplasm.